A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

por Lee, Jieon, Kim, Bo-Hyung, Yu, Kyung-Sang, Kim, Hee Sun, Kim, Ji Duck, Cho, Joo-Youn, Lee, SeungHwan, Gu, Namyi
Publicado 2017